U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
178681178681Prospective Study in Pregnant Women With HypercoagulopathyRecruitingNo Results AvailablePre-Eclampsia|Eclampsiahttps://ClinicalTrials.gov/show/NCT00215969
178682178682A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal CarcinomaCompletedNo Results AvailableRectal NeoplasmsDrug: topotecan|Procedure: radiation|Procedure: surgeryhttps://ClinicalTrials.gov/show/NCT00215956
178683178683Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)TerminatedHas ResultsMultiple MyelomaDrug: zoledronic acid|Drug: dexamethasone|Drug: thalidomide|Drug: vincristine|Drug: adriamycinhttps://ClinicalTrials.gov/show/NCT00215943
178684178684The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung CancerCompletedHas ResultsCarcinoma, Non-Small-Cell LungDrug: Vinorelbine|Drug: Docetaxel|Drug: Gemcitabine|Drug: Carboplatinhttps://ClinicalTrials.gov/show/NCT00215930
178685178685D-Serine Monotherapy for SchizophreniaRecruitingNo Results AvailableSchizophreniaDrug: D-serine 2100 mg dailyhttps://ClinicalTrials.gov/show/NCT00215917
178686178686D-serine Adjuvant Treatment for Parkinson's DiseaseCompletedNo Results AvailableParkinson's DiseaseDrug: D-serine (~2g/day)https://ClinicalTrials.gov/show/NCT00215904
178687178687PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With InterferonCompletedNo Results AvailableChronic Hepatitis C Infection in HIV-Infected Persons|HIV InfectionsDrug: PEG-Interferon a-2b + Ribavirinhttps://ClinicalTrials.gov/show/NCT00215891
178688178688D-serine for Posttraumatic Stress Disorder TreatmentCompletedNo Results AvailablePosttraumatic Stress DisorderDrug: D-serine (~2g /day)https://ClinicalTrials.gov/show/NCT00215878
178689178689PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin TherapyCompletedNo Results AvailableChronic Hepatitis C Virus InfectionDrug: PEGIntron plus ribavirinhttps://ClinicalTrials.gov/show/NCT00215865
178690178690A Randomized, Dose-ranging Study of Alferon LDO in Asymptomatic HIV+ SubjectsTerminatedNo Results AvailableHIV InfectionsDrug: Alferon LDOhttps://ClinicalTrials.gov/show/NCT00215852
178691178691HRN 004- Peginterferon a-2a Plus Ribavirin for Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon TherapyActive, not recruitingNo Results AvailableChronic Hepatitis C Infection in HIV Infected Persons|HIV InfectionsDrug: Peginterferon a-2a plus Ribavirinhttps://ClinicalTrials.gov/show/NCT00215839
178692178692Study of Alferon® LDO (Low Dose Oral) in Normal VolunteersCompletedNo Results AvailableSevere Acute Respiratory SyndromeDrug: Alferon LDOhttps://ClinicalTrials.gov/show/NCT00215826
178693178693Study of Ampligen in Chronic Fatigue SyndromeRecruitingNo Results AvailableChronic Fatigue SyndromeDrug: Poly I: Poly C12Uhttps://ClinicalTrials.gov/show/NCT00215813
178694178694The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue SyndromeCompletedNo Results AvailableChronic Fatigue Syndrome|Myalgic EncephalomyelitisDrug: Ampligenhttps://ClinicalTrials.gov/show/NCT00215800
178695178695Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux DiseaseCompletedHas ResultsNasal Polyps|Gastroesophageal RefluxDrug: lansoprazolehttps://ClinicalTrials.gov/show/NCT00215787
178696178696Flecainide-Short Long Study (Flec-SL)CompletedNo Results AvailableAtrial FibrillationDrug: Flecainidehttps://ClinicalTrials.gov/show/NCT00215774
178697178697Recurrence of Atrial Fibrillation in Patients With Dual-chamber Pacemakers and Drug TherapyCompletedNo Results AvailableAtrial Fibrillationhttps://ClinicalTrials.gov/show/NCT00215761
178698178698Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly DocetaxelTerminatedNo Results AvailableBreast Cancer|Lung CancerDrug: Dexamethasonehttps://ClinicalTrials.gov/show/NCT00215748
178699178699Effect of Platelet Concentrate in Treatment of Diabetic UlcersTerminatedNo Results AvailableDiabetesDevice: debridement, dressing, and APChttps://ClinicalTrials.gov/show/NCT00215735
178700178700XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal CancerActive, not recruitingNo Results AvailableColorectal CarcinomaDrug: Cetuximabhttps://ClinicalTrials.gov/show/NCT00215722
178701178701Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate CancerCompletedNo Results AvailableProstate CancerDrug: docetaxelhttps://ClinicalTrials.gov/show/NCT00215709
178702178702A Study to Treat Patients Whose Chronic Angina Symptoms Are Not Relieved by Medication and Have an Area of the Heart That Cannot be Treated by Standard TherapiesCompletedNo Results AvailableModerate to Severe Angina PectorisGenetic: BioBypass®https://ClinicalTrials.gov/show/NCT00215696
178703178703An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate CancerCompletedHas ResultsProstate CancerDrug: Degarelixhttps://ClinicalTrials.gov/show/NCT00215683
178704178704Study of the Safety, Tolerability and Pharmacokinetics of 1 Mg/Eye and 3 Mg/Eye Pegaptanib Sodium in Patients With Exudative Age-Related Macular Degeneration (AMD)CompletedNo Results AvailableAge-Related Macular DegenerationDrug: pegaptanib sodium (Macugen)https://ClinicalTrials.gov/show/NCT00215670
178705178705Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer PatientsTerminatedHas ResultsProstate CancerDrug: Degarelix|Drug: Degarelix|Drug: Degarelix|Drug: Degarelix|Drug: Degarelix|Drug: Degarelix|Drug: Degarelix|Drug: Degarelixhttps://ClinicalTrials.gov/show/NCT00215657
178706178706MATRIX EG (Matuzumab Treatment With ECX in Esophago-Gastric Cancer)CompletedNo Results AvailableEsophageal Cancer|Gastric CancerDrug: ECX|Drug: Matuzumab + ECXhttps://ClinicalTrials.gov/show/NCT00215644
178707178707Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer?TerminatedNo Results AvailableProstate Cancer|Erectile DysfunctionDrug: tadalafilhttps://ClinicalTrials.gov/show/NCT00215631
178708178708Uterine Balloon Treatment for Heavy Period Bleeding.CompletedNo Results AvailableMenorrhagiaDevice: Uterine Balloon Therapy|Device: Uterine Balloon Therapyhttps://ClinicalTrials.gov/show/NCT00215618
178709178709Study of XL184 (Cabozantinib) in Adults With Advanced MalignanciesCompletedNo Results AvailableLymphoma|Cancer|Thyroid CarcinomaDrug: XL184https://ClinicalTrials.gov/show/NCT00215605
178710178710Open Label, Zonegran (Zonisamide) In Partial Onset SeizuresCompletedNo Results AvailableEpilepsyDrug: Zonegranhttps://ClinicalTrials.gov/show/NCT00215592

* Görseller ve İçerik tekif hakkına sahip olabilir